nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—PTGS1—Thalidomide—leprosy	0.0722	0.096	CbGbCtD
Imatinib—PTGS1—Dapsone—leprosy	0.0577	0.0768	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0559	0.0744	CbGbCtD
Imatinib—CYP3A7—Rifampicin—leprosy	0.0559	0.0744	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0462	0.0614	CbGbCtD
Imatinib—CYP3A7—Dapsone—leprosy	0.0462	0.0614	CbGbCtD
Imatinib—CYP3A5—Thalidomide—leprosy	0.0433	0.0576	CbGbCtD
Imatinib—CYP3A5—Rifampicin—leprosy	0.0419	0.0558	CbGbCtD
Imatinib—CYP2C19—Thalidomide—leprosy	0.0349	0.0465	CbGbCtD
Imatinib—CYP3A5—Dapsone—leprosy	0.0346	0.0461	CbGbCtD
Imatinib—CYP2C19—Rifampicin—leprosy	0.0338	0.045	CbGbCtD
Imatinib—CYP1A2—Thalidomide—leprosy	0.0322	0.0429	CbGbCtD
Imatinib—CYP1A2—Rifampicin—leprosy	0.0312	0.0416	CbGbCtD
Imatinib—CYP2C9—Thalidomide—leprosy	0.029	0.0387	CbGbCtD
Imatinib—CYP2C9—Rifampicin—leprosy	0.0281	0.0374	CbGbCtD
Imatinib—CYP2C19—Dapsone—leprosy	0.0279	0.0372	CbGbCtD
Imatinib—ABCB1—Rifampicin—leprosy	0.0273	0.0363	CbGbCtD
Imatinib—CYP2C9—Dapsone—leprosy	0.0232	0.0309	CbGbCtD
Imatinib—CYP3A4—Rifampicin—leprosy	0.0164	0.0218	CbGbCtD
Imatinib—CYP3A4—Dapsone—leprosy	0.0135	0.018	CbGbCtD
Imatinib—Chronic myeloid leukaemia—Thalidomide—leprosy	0.00942	0.0577	CcSEcCtD
Imatinib—Hypoalbuminaemia—Dapsone—leprosy	0.00795	0.0486	CcSEcCtD
Imatinib—CA6—ear—leprosy	0.00602	0.0831	CbGeAlD
Imatinib—CA3—ear—leprosy	0.0057	0.0787	CbGeAlD
Imatinib—Gastrointestinal perforation—Thalidomide—leprosy	0.0034	0.0208	CcSEcCtD
Imatinib—Tumour lysis syndrome—Thalidomide—leprosy	0.0032	0.0196	CcSEcCtD
Imatinib—Hypoproteinaemia—Thalidomide—leprosy	0.00302	0.0185	CcSEcCtD
Imatinib—ABCA3—eye—leprosy	0.00276	0.0381	CbGeAlD
Imatinib—KIT—skin epidermis—leprosy	0.00258	0.0356	CbGeAlD
Imatinib—Pericarditis—Thalidomide—leprosy	0.00205	0.0126	CcSEcCtD
Imatinib—CA1—nerve—leprosy	0.00201	0.0278	CbGeAlD
Imatinib—Ascites—Thalidomide—leprosy	0.00195	0.012	CcSEcCtD
Imatinib—NTRK1—testis—leprosy	0.00191	0.0264	CbGeAlD
Imatinib—ABCA3—tendon—leprosy	0.00183	0.0252	CbGeAlD
Imatinib—White blood cell count decreased—Thalidomide—leprosy	0.00179	0.0109	CcSEcCtD
Imatinib—Lymphopenia—Thalidomide—leprosy	0.00174	0.0106	CcSEcCtD
Imatinib—Lactic dehydrogenase activity increased—Thalidomide—leprosy	0.00174	0.0106	CcSEcCtD
Imatinib—KIT—blood vessel—leprosy	0.00173	0.0239	CbGeAlD
Imatinib—PDGFRB—blood vessel—leprosy	0.00169	0.0233	CbGeAlD
Imatinib—DDR1—tendon—leprosy	0.00169	0.0233	CbGeAlD
Imatinib—Skin exfoliation—Dapsone—leprosy	0.00166	0.0101	CcSEcCtD
Imatinib—Sexual dysfunction—Thalidomide—leprosy	0.00158	0.0097	CcSEcCtD
Imatinib—HIPK4—testis—leprosy	0.00153	0.0211	CbGeAlD
Imatinib—Gastric ulcer—Thalidomide—leprosy	0.00153	0.00935	CcSEcCtD
Imatinib—Blood lactate dehydrogenase increased—Thalidomide—leprosy	0.00153	0.00935	CcSEcCtD
Imatinib—ABCA3—testis—leprosy	0.00151	0.0209	CbGeAlD
Imatinib—Platelet count decreased—Thalidomide—leprosy	0.00149	0.00914	CcSEcCtD
Imatinib—ABCA3—nervous system—leprosy	0.00148	0.0205	CbGeAlD
Imatinib—Febrile neutropenia—Thalidomide—leprosy	0.00148	0.00904	CcSEcCtD
Imatinib—Psoriasis—Thalidomide—leprosy	0.00141	0.00865	CcSEcCtD
Imatinib—Hypomagnesaemia—Thalidomide—leprosy	0.0014	0.00856	CcSEcCtD
Imatinib—DDR1—testis—leprosy	0.0014	0.0193	CbGeAlD
Imatinib—Embolism—Thalidomide—leprosy	0.00138	0.00847	CcSEcCtD
Imatinib—Nail disorder—Thalidomide—leprosy	0.00137	0.00838	CcSEcCtD
Imatinib—Intestinal obstruction—Thalidomide—leprosy	0.0013	0.00798	CcSEcCtD
Imatinib—Hypercalcaemia—Thalidomide—leprosy	0.00128	0.00782	CcSEcCtD
Imatinib—Interstitial lung disease—Thalidomide—leprosy	0.00126	0.00768	CcSEcCtD
Imatinib—Thrombosis—Thalidomide—leprosy	0.00126	0.00768	CcSEcCtD
Imatinib—Pleural effusion—Thalidomide—leprosy	0.00116	0.0071	CcSEcCtD
Imatinib—Hyperaesthesia—Thalidomide—leprosy	0.00113	0.00693	CcSEcCtD
Imatinib—Nasopharyngitis—Dapsone—leprosy	0.00113	0.00689	CcSEcCtD
Imatinib—Rash pustular—Thalidomide—leprosy	0.00111	0.00682	CcSEcCtD
Imatinib—Muscular weakness—Dapsone—leprosy	0.00111	0.0068	CcSEcCtD
Imatinib—ABL2—tendon—leprosy	0.0011	0.0152	CbGeAlD
Imatinib—Influenza—Dapsone—leprosy	0.00109	0.00666	CcSEcCtD
Imatinib—Petechiae—Thalidomide—leprosy	0.00108	0.00661	CcSEcCtD
Imatinib—Pancreatitis—Dapsone—leprosy	0.00107	0.00653	CcSEcCtD
Imatinib—CA12—eye—leprosy	0.00106	0.0147	CbGeAlD
Imatinib—PIP4K2C—tendon—leprosy	0.00104	0.0144	CbGeAlD
Imatinib—CSF1R—eye—leprosy	0.00101	0.014	CbGeAlD
Imatinib—Photosensitivity reaction—Dapsone—leprosy	0.000994	0.00608	CcSEcCtD
Imatinib—CA3—tendon—leprosy	0.000994	0.0137	CbGeAlD
Imatinib—Musculoskeletal stiffness—Thalidomide—leprosy	0.00099	0.00606	CcSEcCtD
Imatinib—Bone disorder—Thalidomide—leprosy	0.000984	0.00602	CcSEcCtD
Imatinib—Hyperbilirubinaemia—Thalidomide—leprosy	0.000977	0.00598	CcSEcCtD
Imatinib—Cellulitis—Thalidomide—leprosy	0.000977	0.00598	CcSEcCtD
Imatinib—Hypocalcaemia—Thalidomide—leprosy	0.00097	0.00594	CcSEcCtD
Imatinib—Herpes simplex—Thalidomide—leprosy	0.000964	0.0059	CcSEcCtD
Imatinib—Drug interaction—Thalidomide—leprosy	0.000958	0.00586	CcSEcCtD
Imatinib—Hyperuricaemia—Thalidomide—leprosy	0.000958	0.00586	CcSEcCtD
Imatinib—Neuropathy peripheral—Dapsone—leprosy	0.000952	0.00582	CcSEcCtD
Imatinib—CA9—tendon—leprosy	0.000951	0.0131	CbGeAlD
Imatinib—Hearing impaired—Thalidomide—leprosy	0.000933	0.00571	CcSEcCtD
Imatinib—Creatinine increased—Thalidomide—leprosy	0.000933	0.00571	CcSEcCtD
Imatinib—Bone pain—Thalidomide—leprosy	0.000927	0.00567	CcSEcCtD
Imatinib—SLC47A1—eye—leprosy	0.000926	0.0128	CbGeAlD
Imatinib—ABL2—testis—leprosy	0.000911	0.0126	CbGeAlD
Imatinib—Sinusitis—Dapsone—leprosy	0.000911	0.00557	CcSEcCtD
Imatinib—Blood uric acid increased—Thalidomide—leprosy	0.000905	0.00554	CcSEcCtD
Imatinib—CA14—tendon—leprosy	0.000902	0.0124	CbGeAlD
Imatinib—PDGFRB—eye—leprosy	0.000899	0.0124	CbGeAlD
Imatinib—Phosphatase alkaline increased—Thalidomide—leprosy	0.000888	0.00544	CcSEcCtD
Imatinib—CSF1R—skin of body—leprosy	0.000882	0.0122	CbGeAlD
Imatinib—Eructation—Thalidomide—leprosy	0.000873	0.00534	CcSEcCtD
Imatinib—Hyperkalaemia—Thalidomide—leprosy	0.000873	0.00534	CcSEcCtD
Imatinib—Pharyngitis—Dapsone—leprosy	0.000865	0.00529	CcSEcCtD
Imatinib—PIP4K2C—testis—leprosy	0.000862	0.0119	CbGeAlD
Imatinib—Colitis—Thalidomide—leprosy	0.000853	0.00522	CcSEcCtD
Imatinib—Skin exfoliation—Thalidomide—leprosy	0.000848	0.00519	CcSEcCtD
Imatinib—PIP4K2C—nervous system—leprosy	0.000846	0.0117	CbGeAlD
Imatinib—CA1—eye—leprosy	0.000842	0.0116	CbGeAlD
Imatinib—Aplastic anaemia—Thalidomide—leprosy	0.000834	0.0051	CcSEcCtD
Imatinib—CA3—testis—leprosy	0.000823	0.0113	CbGeAlD
Imatinib—Dry eye—Thalidomide—leprosy	0.000821	0.00502	CcSEcCtD
Imatinib—Tinnitus—Dapsone—leprosy	0.000813	0.00497	CcSEcCtD
Imatinib—Oesophagitis—Thalidomide—leprosy	0.000812	0.00497	CcSEcCtD
Imatinib—CA3—nervous system—leprosy	0.000808	0.0111	CbGeAlD
Imatinib—ABL1—eye—leprosy	0.000801	0.0111	CbGeAlD
Imatinib—KIT—skin of body—leprosy	0.000801	0.011	CbGeAlD
Imatinib—Gynaecomastia—Thalidomide—leprosy	0.000795	0.00486	CcSEcCtD
Imatinib—Lightheadedness—Thalidomide—leprosy	0.000795	0.00486	CcSEcCtD
Imatinib—PTGS1—blood vessel—leprosy	0.000792	0.0109	CbGeAlD
Imatinib—Pulmonary oedema—Thalidomide—leprosy	0.000791	0.00484	CcSEcCtD
Imatinib—CA9—testis—leprosy	0.000788	0.0109	CbGeAlD
Imatinib—PDGFRB—skin of body—leprosy	0.000782	0.0108	CbGeAlD
Imatinib—Sepsis—Thalidomide—leprosy	0.000771	0.00472	CcSEcCtD
Imatinib—LCK—testis—leprosy	0.000765	0.0106	CbGeAlD
Imatinib—NQO2—tendon—leprosy	0.000764	0.0105	CbGeAlD
Imatinib—PDGFRA—tendon—leprosy	0.000762	0.0105	CbGeAlD
Imatinib—Erythema—Dapsone—leprosy	0.000759	0.00464	CcSEcCtD
Imatinib—Lymphadenopathy—Thalidomide—leprosy	0.000756	0.00463	CcSEcCtD
Imatinib—Blood alkaline phosphatase increased—Thalidomide—leprosy	0.000741	0.00454	CcSEcCtD
Imatinib—Gastroenteritis—Thalidomide—leprosy	0.000728	0.00445	CcSEcCtD
Imatinib—Vascular purpura—Thalidomide—leprosy	0.000721	0.00441	CcSEcCtD
Imatinib—Deafness—Thalidomide—leprosy	0.000721	0.00441	CcSEcCtD
Imatinib—Eczema—Thalidomide—leprosy	0.000718	0.00439	CcSEcCtD
Imatinib—Vision blurred—Dapsone—leprosy	0.000715	0.00438	CcSEcCtD
Imatinib—Eye pain—Thalidomide—leprosy	0.000714	0.00437	CcSEcCtD
Imatinib—Cardiac failure congestive—Thalidomide—leprosy	0.000711	0.00435	CcSEcCtD
Imatinib—Renal failure acute—Thalidomide—leprosy	0.000699	0.00427	CcSEcCtD
Imatinib—ABL1—skin of body—leprosy	0.000697	0.00961	CbGeAlD
Imatinib—Libido decreased—Thalidomide—leprosy	0.000695	0.00426	CcSEcCtD
Imatinib—Increased appetite—Thalidomide—leprosy	0.000686	0.0042	CcSEcCtD
Imatinib—Dermatitis exfoliative—Thalidomide—leprosy	0.000683	0.00418	CcSEcCtD
Imatinib—Vertigo—Dapsone—leprosy	0.000682	0.00417	CcSEcCtD
Imatinib—Atrial fibrillation—Thalidomide—leprosy	0.000681	0.00416	CcSEcCtD
Imatinib—Dermatitis bullous—Thalidomide—leprosy	0.000675	0.00413	CcSEcCtD
Imatinib—CSF1R—tendon—leprosy	0.000671	0.00926	CbGeAlD
Imatinib—Purpura—Thalidomide—leprosy	0.000669	0.00409	CcSEcCtD
Imatinib—Arthritis—Thalidomide—leprosy	0.000664	0.00406	CcSEcCtD
Imatinib—Cough—Dapsone—leprosy	0.000662	0.00405	CcSEcCtD
Imatinib—Cardiac failure—Thalidomide—leprosy	0.000661	0.00404	CcSEcCtD
Imatinib—Hypoglycaemia—Thalidomide—leprosy	0.000661	0.00404	CcSEcCtD
Imatinib—Lethargy—Thalidomide—leprosy	0.000658	0.00403	CcSEcCtD
Imatinib—Hyponatraemia—Thalidomide—leprosy	0.000647	0.00396	CcSEcCtD
Imatinib—Pain in extremity—Thalidomide—leprosy	0.000645	0.00395	CcSEcCtD
Imatinib—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.000645	0.00395	CcSEcCtD
Imatinib—Disturbance in sexual arousal—Thalidomide—leprosy	0.00064	0.00391	CcSEcCtD
Imatinib—Migraine—Thalidomide—leprosy	0.000635	0.00388	CcSEcCtD
Imatinib—NQO2—testis—leprosy	0.000633	0.00873	CbGeAlD
Imatinib—PDGFRA—testis—leprosy	0.000631	0.00871	CbGeAlD
Imatinib—Face oedema—Thalidomide—leprosy	0.000623	0.00381	CcSEcCtD
Imatinib—NQO2—nervous system—leprosy	0.000621	0.00857	CbGeAlD
Imatinib—PDGFRA—nervous system—leprosy	0.00062	0.00855	CbGeAlD
Imatinib—Cardiac arrest—Thalidomide—leprosy	0.000613	0.00375	CcSEcCtD
Imatinib—SLC47A1—tendon—leprosy	0.000613	0.00846	CbGeAlD
Imatinib—Tachycardia—Dapsone—leprosy	0.000604	0.0037	CcSEcCtD
Imatinib—Blood creatinine increased—Thalidomide—leprosy	0.000604	0.0037	CcSEcCtD
Imatinib—Dehydration—Thalidomide—leprosy	0.0006	0.00367	CcSEcCtD
Imatinib—PDGFRB—tendon—leprosy	0.000595	0.00821	CbGeAlD
Imatinib—Dry skin—Thalidomide—leprosy	0.000591	0.00362	CcSEcCtD
Imatinib—Hypokalaemia—Thalidomide—leprosy	0.000587	0.00359	CcSEcCtD
Imatinib—Breast disorder—Thalidomide—leprosy	0.000583	0.00357	CcSEcCtD
Imatinib—Cramp muscle—Thalidomide—leprosy	0.000581	0.00355	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Thalidomide—leprosy	0.000581	0.00355	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000581	0.00355	CcSEcCtD
Imatinib—CA12—nervous system—leprosy	0.000572	0.00789	CbGeAlD
Imatinib—Alanine aminotransferase increased—Thalidomide—leprosy	0.000569	0.00348	CcSEcCtD
Imatinib—Muscular weakness—Thalidomide—leprosy	0.000569	0.00348	CcSEcCtD
Imatinib—Abdominal distension—Thalidomide—leprosy	0.000561	0.00343	CcSEcCtD
Imatinib—Insomnia—Dapsone—leprosy	0.00056	0.00343	CcSEcCtD
Imatinib—Influenza—Thalidomide—leprosy	0.000557	0.00341	CcSEcCtD
Imatinib—Dysphagia—Thalidomide—leprosy	0.000557	0.00341	CcSEcCtD
Imatinib—CSF1R—testis—leprosy	0.000556	0.00767	CbGeAlD
Imatinib—Eosinophilia—Thalidomide—leprosy	0.000552	0.00338	CcSEcCtD
Imatinib—Pancreatitis—Thalidomide—leprosy	0.000546	0.00334	CcSEcCtD
Imatinib—CA2—eye—leprosy	0.000546	0.00753	CbGeAlD
Imatinib—CSF1R—nervous system—leprosy	0.000546	0.00752	CbGeAlD
Imatinib—Angina pectoris—Thalidomide—leprosy	0.000543	0.00332	CcSEcCtD
Imatinib—ABL1—tendon—leprosy	0.000531	0.00732	CbGeAlD
Imatinib—Pancytopenia—Thalidomide—leprosy	0.000529	0.00324	CcSEcCtD
Imatinib—Neutropenia—Thalidomide—leprosy	0.000521	0.00319	CcSEcCtD
Imatinib—Upper respiratory tract infection—Thalidomide—leprosy	0.000518	0.00317	CcSEcCtD
Imatinib—Pollakiuria—Thalidomide—leprosy	0.000515	0.00315	CcSEcCtD
Imatinib—Erectile dysfunction—Thalidomide—leprosy	0.000513	0.00314	CcSEcCtD
Imatinib—Photosensitivity reaction—Thalidomide—leprosy	0.000509	0.00311	CcSEcCtD
Imatinib—SLC47A1—testis—leprosy	0.000508	0.007	CbGeAlD
Imatinib—Weight increased—Thalidomide—leprosy	0.000507	0.0031	CcSEcCtD
Imatinib—Gastrointestinal pain—Dapsone—leprosy	0.000506	0.0031	CcSEcCtD
Imatinib—KIT—testis—leprosy	0.000505	0.00696	CbGeAlD
Imatinib—Weight decreased—Thalidomide—leprosy	0.000504	0.00309	CcSEcCtD
Imatinib—Hyperglycaemia—Thalidomide—leprosy	0.000503	0.00308	CcSEcCtD
Imatinib—Pneumonia—Thalidomide—leprosy	0.0005	0.00306	CcSEcCtD
Imatinib—SLC47A1—nervous system—leprosy	0.000498	0.00687	CbGeAlD
Imatinib—Infestation—Thalidomide—leprosy	0.000497	0.00304	CcSEcCtD
Imatinib—Infestation NOS—Thalidomide—leprosy	0.000497	0.00304	CcSEcCtD
Imatinib—Depression—Thalidomide—leprosy	0.000496	0.00303	CcSEcCtD
Imatinib—KIT—nervous system—leprosy	0.000495	0.00683	CbGeAlD
Imatinib—PDGFRB—testis—leprosy	0.000493	0.0068	CbGeAlD
Imatinib—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000493	0.00301	CcSEcCtD
Imatinib—Acute coronary syndrome—Thalidomide—leprosy	0.00049	0.003	CcSEcCtD
Imatinib—Body temperature increased—Dapsone—leprosy	0.000489	0.003	CcSEcCtD
Imatinib—Abdominal pain—Dapsone—leprosy	0.000489	0.003	CcSEcCtD
Imatinib—Renal failure—Thalidomide—leprosy	0.000489	0.00299	CcSEcCtD
Imatinib—Neuropathy peripheral—Thalidomide—leprosy	0.000487	0.00298	CcSEcCtD
Imatinib—Myocardial infarction—Thalidomide—leprosy	0.000487	0.00298	CcSEcCtD
Imatinib—Stomatitis—Thalidomide—leprosy	0.000484	0.00296	CcSEcCtD
Imatinib—PDGFRB—nervous system—leprosy	0.000484	0.00667	CbGeAlD
Imatinib—Conjunctivitis—Thalidomide—leprosy	0.000483	0.00296	CcSEcCtD
Imatinib—Sweating—Thalidomide—leprosy	0.000476	0.00292	CcSEcCtD
Imatinib—CA2—skin of body—leprosy	0.000475	0.00655	CbGeAlD
Imatinib—Haematuria—Thalidomide—leprosy	0.000474	0.0029	CcSEcCtD
Imatinib—Epistaxis—Thalidomide—leprosy	0.000469	0.00287	CcSEcCtD
Imatinib—ABCB1—blood vessel—leprosy	0.000468	0.00646	CbGeAlD
Imatinib—Sinusitis—Thalidomide—leprosy	0.000466	0.00285	CcSEcCtD
Imatinib—Agranulocytosis—Thalidomide—leprosy	0.000464	0.00284	CcSEcCtD
Imatinib—ORM1—nervous system—leprosy	0.000454	0.00626	CbGeAlD
Imatinib—CA1—nervous system—leprosy	0.000453	0.00625	CbGeAlD
Imatinib—Rhinitis—Thalidomide—leprosy	0.000447	0.00274	CcSEcCtD
Imatinib—Hepatitis—Thalidomide—leprosy	0.000446	0.00273	CcSEcCtD
Imatinib—Hypoaesthesia—Thalidomide—leprosy	0.000444	0.00272	CcSEcCtD
Imatinib—Pharyngitis—Thalidomide—leprosy	0.000443	0.00271	CcSEcCtD
Imatinib—Urinary tract disorder—Thalidomide—leprosy	0.000441	0.0027	CcSEcCtD
Imatinib—Oedema peripheral—Thalidomide—leprosy	0.000439	0.00269	CcSEcCtD
Imatinib—ABL1—testis—leprosy	0.000439	0.00606	CbGeAlD
Imatinib—Urethral disorder—Thalidomide—leprosy	0.000437	0.00268	CcSEcCtD
Imatinib—ABL1—nervous system—leprosy	0.000431	0.00595	CbGeAlD
Imatinib—Erythema multiforme—Thalidomide—leprosy	0.000422	0.00258	CcSEcCtD
Imatinib—Eye disorder—Thalidomide—leprosy	0.000417	0.00255	CcSEcCtD
Imatinib—Tinnitus—Thalidomide—leprosy	0.000416	0.00255	CcSEcCtD
Imatinib—SLC22A1—nervous system—leprosy	0.000416	0.00573	CbGeAlD
Imatinib—Cardiac disorder—Thalidomide—leprosy	0.000414	0.00253	CcSEcCtD
Imatinib—ALB—testis—leprosy	0.000405	0.00559	CbGeAlD
Imatinib—Angiopathy—Thalidomide—leprosy	0.000405	0.00248	CcSEcCtD
Imatinib—Immune system disorder—Thalidomide—leprosy	0.000403	0.00247	CcSEcCtD
Imatinib—Mediastinal disorder—Thalidomide—leprosy	0.000402	0.00246	CcSEcCtD
Imatinib—Chills—Thalidomide—leprosy	0.0004	0.00245	CcSEcCtD
Imatinib—Arrhythmia—Thalidomide—leprosy	0.000399	0.00244	CcSEcCtD
Imatinib—Alopecia—Thalidomide—leprosy	0.000394	0.00241	CcSEcCtD
Imatinib—Vomiting—Dapsone—leprosy	0.000394	0.00241	CcSEcCtD
Imatinib—Mental disorder—Thalidomide—leprosy	0.000391	0.00239	CcSEcCtD
Imatinib—Malnutrition—Thalidomide—leprosy	0.000388	0.00238	CcSEcCtD
Imatinib—Headache—Dapsone—leprosy	0.000388	0.00237	CcSEcCtD
Imatinib—Flatulence—Thalidomide—leprosy	0.000383	0.00234	CcSEcCtD
Imatinib—Dysgeusia—Thalidomide—leprosy	0.00038	0.00233	CcSEcCtD
Imatinib—Back pain—Thalidomide—leprosy	0.000376	0.0023	CcSEcCtD
Imatinib—Muscle spasms—Thalidomide—leprosy	0.000373	0.00228	CcSEcCtD
Imatinib—Nausea—Dapsone—leprosy	0.000368	0.00225	CcSEcCtD
Imatinib—PTGS1—skin of body—leprosy	0.000367	0.00506	CbGeAlD
Imatinib—Vision blurred—Thalidomide—leprosy	0.000366	0.00224	CcSEcCtD
Imatinib—Tremor—Thalidomide—leprosy	0.000364	0.00223	CcSEcCtD
Imatinib—CA2—tendon—leprosy	0.000361	0.00498	CbGeAlD
Imatinib—Ill-defined disorder—Thalidomide—leprosy	0.00036	0.0022	CcSEcCtD
Imatinib—Anaemia—Thalidomide—leprosy	0.000359	0.0022	CcSEcCtD
Imatinib—Angioedema—Thalidomide—leprosy	0.000355	0.00217	CcSEcCtD
Imatinib—Malaise—Thalidomide—leprosy	0.00035	0.00214	CcSEcCtD
Imatinib—Vertigo—Thalidomide—leprosy	0.000349	0.00214	CcSEcCtD
Imatinib—Syncope—Thalidomide—leprosy	0.000348	0.00213	CcSEcCtD
Imatinib—Leukopenia—Thalidomide—leprosy	0.000348	0.00213	CcSEcCtD
Imatinib—Palpitations—Thalidomide—leprosy	0.000343	0.0021	CcSEcCtD
Imatinib—Loss of consciousness—Thalidomide—leprosy	0.000341	0.00209	CcSEcCtD
Imatinib—Cough—Thalidomide—leprosy	0.000339	0.00207	CcSEcCtD
Imatinib—Convulsion—Thalidomide—leprosy	0.000336	0.00206	CcSEcCtD
Imatinib—Hypertension—Thalidomide—leprosy	0.000335	0.00205	CcSEcCtD
Imatinib—Arthralgia—Thalidomide—leprosy	0.000331	0.00202	CcSEcCtD
Imatinib—Myalgia—Thalidomide—leprosy	0.000331	0.00202	CcSEcCtD
Imatinib—Chest pain—Thalidomide—leprosy	0.000331	0.00202	CcSEcCtD
Imatinib—Anxiety—Thalidomide—leprosy	0.000329	0.00202	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000328	0.00201	CcSEcCtD
Imatinib—Discomfort—Thalidomide—leprosy	0.000327	0.002	CcSEcCtD
Imatinib—Dry mouth—Thalidomide—leprosy	0.000323	0.00198	CcSEcCtD
Imatinib—Confusional state—Thalidomide—leprosy	0.00032	0.00196	CcSEcCtD
Imatinib—Oedema—Thalidomide—leprosy	0.000317	0.00194	CcSEcCtD
Imatinib—Infection—Thalidomide—leprosy	0.000315	0.00193	CcSEcCtD
Imatinib—Shock—Thalidomide—leprosy	0.000312	0.00191	CcSEcCtD
Imatinib—Nervous system disorder—Thalidomide—leprosy	0.000311	0.0019	CcSEcCtD
Imatinib—Thrombocytopenia—Thalidomide—leprosy	0.00031	0.0019	CcSEcCtD
Imatinib—Tachycardia—Thalidomide—leprosy	0.000309	0.00189	CcSEcCtD
Imatinib—Skin disorder—Thalidomide—leprosy	0.000308	0.00188	CcSEcCtD
Imatinib—Hyperhidrosis—Thalidomide—leprosy	0.000306	0.00187	CcSEcCtD
Imatinib—Anorexia—Thalidomide—leprosy	0.000302	0.00185	CcSEcCtD
Imatinib—CA2—testis—leprosy	0.000299	0.00413	CbGeAlD
Imatinib—Hypotension—Thalidomide—leprosy	0.000296	0.00181	CcSEcCtD
Imatinib—CA2—nervous system—leprosy	0.000294	0.00405	CbGeAlD
Imatinib—Musculoskeletal discomfort—Thalidomide—leprosy	0.000289	0.00177	CcSEcCtD
Imatinib—Insomnia—Thalidomide—leprosy	0.000287	0.00175	CcSEcCtD
Imatinib—Paraesthesia—Thalidomide—leprosy	0.000285	0.00174	CcSEcCtD
Imatinib—Dyspnoea—Thalidomide—leprosy	0.000283	0.00173	CcSEcCtD
Imatinib—Somnolence—Thalidomide—leprosy	0.000282	0.00172	CcSEcCtD
Imatinib—PTGS1—tendon—leprosy	0.000279	0.00385	CbGeAlD
Imatinib—Dyspepsia—Thalidomide—leprosy	0.000279	0.00171	CcSEcCtD
Imatinib—ABCG2—testis—leprosy	0.000277	0.00382	CbGeAlD
Imatinib—Decreased appetite—Thalidomide—leprosy	0.000276	0.00169	CcSEcCtD
Imatinib—Gastrointestinal disorder—Thalidomide—leprosy	0.000274	0.00167	CcSEcCtD
Imatinib—Fatigue—Thalidomide—leprosy	0.000273	0.00167	CcSEcCtD
Imatinib—Pain—Thalidomide—leprosy	0.000271	0.00166	CcSEcCtD
Imatinib—Constipation—Thalidomide—leprosy	0.000271	0.00166	CcSEcCtD
Imatinib—Feeling abnormal—Thalidomide—leprosy	0.000261	0.0016	CcSEcCtD
Imatinib—Gastrointestinal pain—Thalidomide—leprosy	0.000259	0.00159	CcSEcCtD
Imatinib—Urticaria—Thalidomide—leprosy	0.000252	0.00154	CcSEcCtD
Imatinib—Body temperature increased—Thalidomide—leprosy	0.000251	0.00153	CcSEcCtD
Imatinib—Abdominal pain—Thalidomide—leprosy	0.000251	0.00153	CcSEcCtD
Imatinib—Hypersensitivity—Thalidomide—leprosy	0.000234	0.00143	CcSEcCtD
Imatinib—PTGS1—testis—leprosy	0.000231	0.00319	CbGeAlD
Imatinib—Asthenia—Thalidomide—leprosy	0.000227	0.00139	CcSEcCtD
Imatinib—PTGS1—nervous system—leprosy	0.000227	0.00313	CbGeAlD
Imatinib—Pruritus—Thalidomide—leprosy	0.000224	0.00137	CcSEcCtD
Imatinib—Diarrhoea—Thalidomide—leprosy	0.000217	0.00133	CcSEcCtD
Imatinib—Dizziness—Thalidomide—leprosy	0.00021	0.00128	CcSEcCtD
Imatinib—Vomiting—Thalidomide—leprosy	0.000202	0.00123	CcSEcCtD
Imatinib—Rash—Thalidomide—leprosy	0.0002	0.00122	CcSEcCtD
Imatinib—Dermatitis—Thalidomide—leprosy	0.0002	0.00122	CcSEcCtD
Imatinib—Headache—Thalidomide—leprosy	0.000199	0.00122	CcSEcCtD
Imatinib—CYP2D6—testis—leprosy	0.00019	0.00262	CbGeAlD
Imatinib—CYP3A4—nervous system—leprosy	0.000189	0.00261	CbGeAlD
Imatinib—Nausea—Thalidomide—leprosy	0.000188	0.00115	CcSEcCtD
Imatinib—CYP2D6—nervous system—leprosy	0.000186	0.00257	CbGeAlD
Imatinib—ABCB1—testis—leprosy	0.000137	0.00188	CbGeAlD
Imatinib—ABCB1—nervous system—leprosy	0.000134	0.00185	CbGeAlD
Imatinib—CSF1R—C-MYB transcription factor network—CD4—leprosy	0.000127	0.00992	CbGpPWpGaD
Imatinib—LCK—PD-1 signaling—CD4—leprosy	0.000122	0.00956	CbGpPWpGaD
Imatinib—NTRK1—SHP2 signaling—IFNG—leprosy	0.00012	0.00942	CbGpPWpGaD
Imatinib—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000117	0.00914	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—IL10—leprosy	0.000111	0.00868	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—CD40LG—leprosy	0.000111	0.00868	CbGpPWpGaD
Imatinib—LCK—TCR signaling in naïve CD8+ T cells—CD8A—leprosy	0.000109	0.00854	CbGpPWpGaD
Imatinib—LCK—Downstream TCR signaling—HLA-DRB1—leprosy	0.000109	0.00854	CbGpPWpGaD
Imatinib—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—leprosy	0.000109	0.00852	CbGpPWpGaD
Imatinib—NTRK1—SHP2 signaling—IL2—leprosy	0.000107	0.00837	CbGpPWpGaD
Imatinib—LCK—The role of Nef in HIV-1 replication and disease pathogenesis—CD4—leprosy	0.000104	0.00817	CbGpPWpGaD
Imatinib—LCK—Inflammatory Response Pathway—IFNG—leprosy	0.000102	0.00801	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—CD8A—leprosy	9.87e-05	0.00773	CbGpPWpGaD
Imatinib—CA3—Metabolism—SDHD—leprosy	9.59e-05	0.00751	CbGpPWpGaD
Imatinib—CA1—C-MYB transcription factor network—CD4—leprosy	9.45e-05	0.0074	CbGpPWpGaD
Imatinib—LCK—Generation of second messenger molecules—CD4—leprosy	9.38e-05	0.00734	CbGpPWpGaD
Imatinib—LCK—T-Cell Receptor and Co-stimulatory Signaling—IL2—leprosy	9.33e-05	0.00731	CbGpPWpGaD
Imatinib—LCK—Inflammatory Response Pathway—IL2—leprosy	9.08e-05	0.00712	CbGpPWpGaD
Imatinib—LCK—IL2 signaling events mediated by STAT5—IL2—leprosy	9.08e-05	0.00712	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—HLA-DRB1—leprosy	8.92e-05	0.00699	CbGpPWpGaD
Imatinib—PTGS1—Overview of nanoparticle effects—TNF—leprosy	8.87e-05	0.00695	CbGpPWpGaD
Imatinib—PDGFRA—ATF-2 transcription factor network—IFNG—leprosy	8.23e-05	0.00645	CbGpPWpGaD
Imatinib—SLC47A1—Transmembrane transport of small molecules—SLC11A1—leprosy	8.22e-05	0.00644	CbGpPWpGaD
Imatinib—LCK—TCR signaling—HLA-DRB1—leprosy	8.15e-05	0.00638	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—RIPK2—leprosy	8.14e-05	0.00638	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—HLA-DRB1—leprosy	8.04e-05	0.0063	CbGpPWpGaD
Imatinib—LCK—Downstream TCR signaling—CD4—leprosy	7.69e-05	0.00602	CbGpPWpGaD
Imatinib—LCK—IL2 signaling events mediated by PI3K—IL2—leprosy	7.68e-05	0.00602	CbGpPWpGaD
Imatinib—PDGFRB—SHP2 signaling—IFNG—leprosy	7.52e-05	0.00589	CbGpPWpGaD
Imatinib—LCK—TCR signaling in naïve CD4+ T cells—HLA-DRB1—leprosy	7.45e-05	0.00583	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—RIPK2—leprosy	7.45e-05	0.00583	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—NOD2—leprosy	7.38e-05	0.00578	CbGpPWpGaD
Imatinib—LCK—Costimulation by the CD28 family—HLA-DRB1—leprosy	7.27e-05	0.0057	CbGpPWpGaD
Imatinib—LCK—IL-2 Signaling Pathway—IL2—leprosy	6.94e-05	0.00544	CbGpPWpGaD
Imatinib—PDGFRB—SHP2 signaling—IL2—leprosy	6.68e-05	0.00523	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—IFNG—leprosy	6.52e-05	0.0051	CbGpPWpGaD
Imatinib—ABL1—Regulation of Telomerase—IFNG—leprosy	6.45e-05	0.00505	CbGpPWpGaD
Imatinib—LCK—IL2-mediated signaling events—IFNG—leprosy	6.39e-05	0.005	CbGpPWpGaD
Imatinib—LCK—Interleukin-2 signaling—IL2—leprosy	6.34e-05	0.00497	CbGpPWpGaD
Imatinib—KIT—C-MYB transcription factor network—CD4—leprosy	6.33e-05	0.00496	CbGpPWpGaD
Imatinib—CA14—Metabolism—SDHD—leprosy	6.18e-05	0.00484	CbGpPWpGaD
Imatinib—LCK—CXCR4-mediated signaling events—HLA-DRB1—leprosy	6.14e-05	0.00481	CbGpPWpGaD
Imatinib—LCK—GPVI-mediated activation cascade—IL2—leprosy	6.13e-05	0.00481	CbGpPWpGaD
Imatinib—LCK—SHP2 signaling—IFNG—leprosy	6.03e-05	0.00473	CbGpPWpGaD
Imatinib—CA6—Metabolism—SDHD—leprosy	6.02e-05	0.00472	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—IFNG—leprosy	5.87e-05	0.0046	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—IL2—leprosy	5.79e-05	0.00454	CbGpPWpGaD
Imatinib—LCK—TCR signaling—CD4—leprosy	5.75e-05	0.0045	CbGpPWpGaD
Imatinib—ABL1—Regulation of Telomerase—IL2—leprosy	5.73e-05	0.00449	CbGpPWpGaD
Imatinib—LCK—IL2-mediated signaling events—IL2—leprosy	5.68e-05	0.00445	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—CD4—leprosy	5.67e-05	0.00444	CbGpPWpGaD
Imatinib—CA7—Metabolism—SDHD—leprosy	5.62e-05	0.0044	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—RIPK2—leprosy	5.46e-05	0.00427	CbGpPWpGaD
Imatinib—LCK—SHP2 signaling—IL2—leprosy	5.36e-05	0.0042	CbGpPWpGaD
Imatinib—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—leprosy	5.3e-05	0.00415	CbGpPWpGaD
Imatinib—LCK—TCR signaling in naïve CD4+ T cells—CD4—leprosy	5.25e-05	0.00412	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—IL2—leprosy	5.22e-05	0.00409	CbGpPWpGaD
Imatinib—CA12—Metabolism—SDHD—leprosy	5.21e-05	0.00408	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—RIPK2—leprosy	5.17e-05	0.00405	CbGpPWpGaD
Imatinib—LCK—Costimulation by the CD28 family—CD4—leprosy	5.13e-05	0.00402	CbGpPWpGaD
Imatinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—leprosy	5.1e-05	0.00399	CbGpPWpGaD
Imatinib—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—leprosy	4.94e-05	0.00387	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CYLD—leprosy	4.83e-05	0.00378	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—RIPK2—leprosy	4.65e-05	0.00365	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CYLD—leprosy	4.57e-05	0.00358	CbGpPWpGaD
Imatinib—LCK—CXCR4-mediated signaling events—CD4—leprosy	4.33e-05	0.00339	CbGpPWpGaD
Imatinib—PDGFRA—Allograft Rejection—TNF—leprosy	4.22e-05	0.0033	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—CD40LG—leprosy	4.2e-05	0.00329	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—IL10—leprosy	4.2e-05	0.00329	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CYLD—leprosy	4.12e-05	0.00323	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—PARK2—leprosy	4.1e-05	0.00321	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—IFNG—leprosy	4.02e-05	0.00315	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CYLD—leprosy	4.01e-05	0.00314	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—IFNG—leprosy	4e-05	0.00313	CbGpPWpGaD
Imatinib—CA2—Metabolism—SDHD—leprosy	3.98e-05	0.00312	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—PARK2—leprosy	3.88e-05	0.00304	CbGpPWpGaD
Imatinib—CA1—Metabolism—SDHD—leprosy	3.82e-05	0.00299	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—RIPK2—leprosy	3.8e-05	0.00298	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—RIPK2—leprosy	3.73e-05	0.00293	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—PARK2—leprosy	3.5e-05	0.00274	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—NOD2—leprosy	3.44e-05	0.0027	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—HLA-DRB1—leprosy	3.38e-05	0.00265	CbGpPWpGaD
Imatinib—CA9—Metabolism—SDHD—leprosy	3.36e-05	0.00263	CbGpPWpGaD
Imatinib—NTRK1—MAPK Signaling Pathway—TNF—leprosy	3.33e-05	0.0026	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CYLD—leprosy	3.31e-05	0.00259	CbGpPWpGaD
Imatinib—ALB—SLC-mediated transmembrane transport—SLC11A1—leprosy	3.31e-05	0.00259	CbGpPWpGaD
Imatinib—LCK—Signaling by Interleukins—IL2—leprosy	3.26e-05	0.00255	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—IFNG—leprosy	3.25e-05	0.00255	CbGpPWpGaD
Imatinib—LCK—Host Interactions of HIV factors—CD4—leprosy	3.13e-05	0.00245	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—RIPK2—leprosy	3.11e-05	0.00244	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—TLR2—leprosy	3.11e-05	0.00244	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—leprosy	3.04e-05	0.00238	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	3e-05	0.00235	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—RIPK2—leprosy	2.99e-05	0.00234	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—RIPK2—leprosy	2.95e-05	0.00231	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—TLR2—leprosy	2.95e-05	0.00231	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—IL2—leprosy	2.89e-05	0.00226	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—RIPK2—leprosy	2.83e-05	0.00222	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—NOD2—leprosy	2.82e-05	0.00221	CbGpPWpGaD
Imatinib—KIT—Immune System—CYLD—leprosy	2.81e-05	0.0022	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—PARK2—leprosy	2.81e-05	0.0022	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—SLC11A1—leprosy	2.72e-05	0.00213	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—leprosy	2.7e-05	0.00211	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—SLC11A1—leprosy	2.69e-05	0.00211	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—NOD2—leprosy	2.67e-05	0.00209	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CYLD—leprosy	2.66e-05	0.00209	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—TLR2—leprosy	2.65e-05	0.00208	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—RIPK2—leprosy	2.65e-05	0.00208	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—TNF—leprosy	2.6e-05	0.00204	CbGpPWpGaD
Imatinib—ALB—Vitamin B12 Metabolism—TNF—leprosy	2.59e-05	0.00203	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—RIPK2—leprosy	2.59e-05	0.00203	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—TLR2—leprosy	2.59e-05	0.00203	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—IFNG—leprosy	2.58e-05	0.00202	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—RIPK2—leprosy	2.55e-05	0.002	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—SLC11A1—leprosy	2.51e-05	0.00197	CbGpPWpGaD
Imatinib—KIT—Immune System—PARK2—leprosy	2.49e-05	0.00195	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—IFNG—leprosy	2.47e-05	0.00193	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—TNF—leprosy	2.42e-05	0.0019	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—NOD2—leprosy	2.41e-05	0.00189	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CYLD—leprosy	2.4e-05	0.00188	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—PARK2—leprosy	2.35e-05	0.00184	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—NOD2—leprosy	2.35e-05	0.00184	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—HLA-DRB1—leprosy	2.34e-05	0.00184	CbGpPWpGaD
Imatinib—ABL1—Immune System—CYLD—leprosy	2.34e-05	0.00183	CbGpPWpGaD
Imatinib—KIT—Disease—SLC11A1—leprosy	2.3e-05	0.0018	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD40LG—leprosy	2.29e-05	0.00179	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD8A—leprosy	2.27e-05	0.00177	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—IL2—leprosy	2.19e-05	0.00172	CbGpPWpGaD
Imatinib—PDGFRA—Disease—SLC11A1—leprosy	2.17e-05	0.0017	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD40LG—leprosy	2.17e-05	0.0017	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD8A—leprosy	2.14e-05	0.00168	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—RIPK2—leprosy	2.13e-05	0.00167	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—TLR2—leprosy	2.13e-05	0.00167	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—PARK2—leprosy	2.12e-05	0.00166	CbGpPWpGaD
Imatinib—ALB—Folate Metabolism—TNF—leprosy	2.1e-05	0.00165	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TNF—leprosy	2.08e-05	0.00163	CbGpPWpGaD
Imatinib—PDGFRB—MAPK Signaling Pathway—TNF—leprosy	2.08e-05	0.00163	CbGpPWpGaD
Imatinib—ABL1—Immune System—PARK2—leprosy	2.07e-05	0.00162	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—RIPK2—leprosy	2.05e-05	0.0016	CbGpPWpGaD
Imatinib—LCK—HIV Infection—CD4—leprosy	2.04e-05	0.00159	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—leprosy	1.97e-05	0.00154	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—leprosy	1.97e-05	0.00154	CbGpPWpGaD
Imatinib—PDGFRB—Disease—SLC11A1—leprosy	1.96e-05	0.00153	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD40LG—leprosy	1.95e-05	0.00153	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD8A—leprosy	1.93e-05	0.00151	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—NOD2—leprosy	1.93e-05	0.00151	CbGpPWpGaD
Imatinib—LCK—Immune System—CYLD—leprosy	1.93e-05	0.00151	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—HLA-DRB1—leprosy	1.84e-05	0.00144	CbGpPWpGaD
Imatinib—LCK—Platelet activation, signaling and aggregation—IL2—leprosy	1.84e-05	0.00144	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	1.83e-05	0.00143	CbGpPWpGaD
Imatinib—KIT—Immune System—RIPK2—leprosy	1.81e-05	0.00142	CbGpPWpGaD
Imatinib—KIT—Immune System—TLR2—leprosy	1.81e-05	0.00142	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—HLA-DRB1—leprosy	1.75e-05	0.00137	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—RIPK2—leprosy	1.72e-05	0.00134	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—TLR2—leprosy	1.72e-05	0.00134	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IFNG—leprosy	1.71e-05	0.00134	CbGpPWpGaD
Imatinib—LCK—Immune System—PARK2—leprosy	1.7e-05	0.00133	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—SDHD—leprosy	1.7e-05	0.00133	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—SDHD—leprosy	1.68e-05	0.00132	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—SLC11A1—leprosy	1.68e-05	0.00132	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—SDHD—leprosy	1.68e-05	0.00131	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—TNF—leprosy	1.67e-05	0.00131	CbGpPWpGaD
Imatinib—KIT—Immune System—NOD2—leprosy	1.64e-05	0.00129	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—SDHD—leprosy	1.63e-05	0.00128	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—RIPK2—leprosy	1.6e-05	0.00125	CbGpPWpGaD
Imatinib—ABCB1—Allograft Rejection—TNF—leprosy	1.6e-05	0.00125	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—HLA-DRB1—leprosy	1.57e-05	0.00123	CbGpPWpGaD
Imatinib—LCK—Disease—SLC11A1—leprosy	1.57e-05	0.00123	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD40LG—leprosy	1.57e-05	0.00123	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—SDHD—leprosy	1.56e-05	0.00123	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NOD2—leprosy	1.56e-05	0.00122	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD8A—leprosy	1.55e-05	0.00121	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—RIPK2—leprosy	1.55e-05	0.00121	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—TLR2—leprosy	1.55e-05	0.00121	CbGpPWpGaD
Imatinib—LCK—Cytokine Signaling in Immune system—IL2—leprosy	1.52e-05	0.00119	CbGpPWpGaD
Imatinib—ABL1—Immune System—RIPK2—leprosy	1.51e-05	0.00118	CbGpPWpGaD
Imatinib—ABL1—Immune System—TLR2—leprosy	1.51e-05	0.00118	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—leprosy	1.47e-05	0.00115	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NOD2—leprosy	1.4e-05	0.0011	CbGpPWpGaD
Imatinib—KIT—Immune System—CD40LG—leprosy	1.39e-05	0.00109	CbGpPWpGaD
Imatinib—KIT—Immune System—CD8A—leprosy	1.37e-05	0.00108	CbGpPWpGaD
Imatinib—ABL1—Immune System—NOD2—leprosy	1.37e-05	0.00107	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—CD4—leprosy	1.35e-05	0.00106	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD40LG—leprosy	1.32e-05	0.00103	CbGpPWpGaD
Imatinib—KIT—Adaptive Immune System—CD4—leprosy	1.3e-05	0.00102	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD8A—leprosy	1.3e-05	0.00102	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—CD4—leprosy	1.28e-05	0.001	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—HLA-DRB1—leprosy	1.26e-05	0.000989	CbGpPWpGaD
Imatinib—LCK—Immune System—TLR2—leprosy	1.24e-05	0.000972	CbGpPWpGaD
Imatinib—LCK—Immune System—RIPK2—leprosy	1.24e-05	0.000972	CbGpPWpGaD
Imatinib—PDGFRA—Adaptive Immune System—CD4—leprosy	1.23e-05	0.000965	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—SDHD—leprosy	1.22e-05	0.000952	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD40LG—leprosy	1.19e-05	0.000928	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—RIPK2—leprosy	1.17e-05	0.000918	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD8A—leprosy	1.17e-05	0.000918	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—CD4—leprosy	1.16e-05	0.000905	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD40LG—leprosy	1.15e-05	0.000905	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—IL2—leprosy	1.15e-05	0.000901	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD8A—leprosy	1.14e-05	0.000894	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—CD4—leprosy	1.13e-05	0.000882	CbGpPWpGaD
Imatinib—LCK—Immune System—NOD2—leprosy	1.12e-05	0.000881	CbGpPWpGaD
Imatinib—KIT—Immune System—HLA-DRB1—leprosy	1.12e-05	0.000876	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—RIPK2—leprosy	1.11e-05	0.000869	CbGpPWpGaD
Imatinib—PDGFRB—Adaptive Immune System—CD4—leprosy	1.11e-05	0.000869	CbGpPWpGaD
Imatinib—ALB—Platelet activation, signaling and aggregation—IL2—leprosy	1.1e-05	0.000861	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—HLA-DRB1—leprosy	1.06e-05	0.00083	CbGpPWpGaD
Imatinib—ALB—Metabolism—SDHD—leprosy	1.05e-05	0.00082	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—RIPK2—leprosy	1e-05	0.000783	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—HLA-DRB1—leprosy	9.54e-06	0.000747	CbGpPWpGaD
Imatinib—LCK—Immune System—CD40LG—leprosy	9.51e-06	0.000745	CbGpPWpGaD
Imatinib—LCK—Hemostasis—IL2—leprosy	9.48e-06	0.000742	CbGpPWpGaD
Imatinib—LCK—Immune System—CD8A—leprosy	9.4e-06	0.000737	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—SDHD—leprosy	9.4e-06	0.000736	CbGpPWpGaD
Imatinib—ABL1—Immune System—HLA-DRB1—leprosy	9.3e-06	0.000728	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—CD4—leprosy	9.27e-06	0.000726	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—SDHD—leprosy	9.17e-06	0.000718	CbGpPWpGaD
Imatinib—LCK—Adaptive Immune System—CD4—leprosy	8.9e-06	0.000697	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—SDHD—leprosy	8.64e-06	0.000677	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—SDHD—leprosy	8.57e-06	0.000671	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TNF—leprosy	8.54e-06	0.000669	CbGpPWpGaD
Imatinib—KIT—Immune System—IFNG—leprosy	8.17e-06	0.00064	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—RIPK2—leprosy	8.02e-06	0.000628	CbGpPWpGaD
Imatinib—KIT—Immune System—CD4—leprosy	7.89e-06	0.000618	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—leprosy	7.88e-06	0.000617	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IFNG—leprosy	7.73e-06	0.000606	CbGpPWpGaD
Imatinib—LCK—Immune System—HLA-DRB1—leprosy	7.66e-06	0.0006	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—CD4—leprosy	7.47e-06	0.000585	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—SDHD—leprosy	7.32e-06	0.000573	CbGpPWpGaD
Imatinib—KIT—Disease—CD4—leprosy	7.29e-06	0.000571	CbGpPWpGaD
Imatinib—KIT—Immune System—IL2—leprosy	7.26e-06	0.000569	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IFNG—leprosy	6.97e-06	0.000546	CbGpPWpGaD
Imatinib—PDGFRA—Disease—CD4—leprosy	6.9e-06	0.00054	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL2—leprosy	6.87e-06	0.000538	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—leprosy	6.79e-06	0.000532	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—leprosy	6.73e-06	0.000527	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—leprosy	6.56e-06	0.000514	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—leprosy	6.41e-06	0.000502	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—leprosy	6.21e-06	0.000487	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—leprosy	6.19e-06	0.000485	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—leprosy	6.03e-06	0.000473	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—leprosy	5.66e-06	0.000444	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SDHD—leprosy	5.65e-06	0.000443	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—leprosy	5.59e-06	0.000438	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—leprosy	5.4e-06	0.000423	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—leprosy	4.99e-06	0.000391	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—leprosy	4.97e-06	0.000389	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—leprosy	4.69e-06	0.000368	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—leprosy	4.44e-06	0.000348	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—leprosy	4e-06	0.000314	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—leprosy	3.21e-06	0.000252	CbGpPWpGaD
